Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.51
IVC's Cash-to-Debt is ranked lower than
68% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. IVC: 0.51 )
Ranked among companies with meaningful Cash-to-Debt only.
IVC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.06 Max: N/A
Current: 0.51
Equity-to-Asset 0.47
IVC's Equity-to-Asset is ranked lower than
70% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. IVC: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
IVC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.47 Max: 0.61
Current: 0.47
0.26
0.61
Piotroski F-Score: 3
Altman Z-Score: 2.37
Beneish M-Score: -2.62
WACC vs ROIC
19.24%
-1.51%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -2.03
IVC's Operating Margin % is ranked lower than
56% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. IVC: -2.03 )
Ranked among companies with meaningful Operating Margin % only.
IVC' s Operating Margin % Range Over the Past 10 Years
Min: -4.63  Med: 0.17 Max: 4.99
Current: -2.03
-4.63
4.99
Net Margin % -4.99
IVC's Net Margin % is ranked lower than
59% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. IVC: -4.99 )
Ranked among companies with meaningful Net Margin % only.
IVC' s Net Margin % Range Over the Past 10 Years
Min: -4.99  Med: 0.1 Max: 2.48
Current: -4.99
-4.99
2.48
ROE % -11.38
IVC's ROE % is ranked lower than
61% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. IVC: -11.38 )
Ranked among companies with meaningful ROE % only.
IVC' s ROE % Range Over the Past 10 Years
Min: -11.38  Med: 0.26 Max: 6.67
Current: -11.38
-11.38
6.67
ROA % -5.45
IVC's ROA % is ranked lower than
56% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. IVC: -5.45 )
Ranked among companies with meaningful ROA % only.
IVC' s ROA % Range Over the Past 10 Years
Min: -5.45  Med: 0.11 Max: 3.08
Current: -5.45
-5.45
3.08
ROC (Joel Greenblatt) % -11.37
IVC's ROC (Joel Greenblatt) % is ranked lower than
55% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. IVC: -11.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
IVC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -29.81  Med: 0.92 Max: 23.37
Current: -11.37
-29.81
23.37
3-Year Revenue Growth Rate -8.30
IVC's 3-Year Revenue Growth Rate is ranked lower than
77% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. IVC: -8.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
IVC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -8.3  Med: 7.5 Max: 18.5
Current: -8.3
-8.3
18.5
3-Year EPS without NRI Growth Rate -8.10
IVC's 3-Year EPS without NRI Growth Rate is ranked lower than
64% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. IVC: -8.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
IVC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -74.2  Med: 19.1 Max: 239.1
Current: -8.1
-74.2
239.1
GuruFocus has detected 6 Warning Signs with Invacare Corp $IVC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» IVC's 30-Y Financials

Financials (Next Earnings Date: 2017-08-08 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

IVC Guru Trades in Q2 2016

Mariko Gordon 1,286,495 sh (New)
Arnold Schneider 146,505 sh (New)
Charles Brandes 951,052 sh (+754.26%)
Barrow, Hanley, Mewhinney & Strauss 254,128 sh (+22.45%)
Joel Greenblatt Sold Out
HOTCHKIS & WILEY 1,397,105 sh (-0.98%)
Chuck Royce 872,850 sh (-5.19%)
Jim Simons 322,400 sh (-6.28%)
» More
Q3 2016

IVC Guru Trades in Q3 2016

Mariko Gordon 2,983,947 sh (+131.94%)
Charles Brandes 1,436,472 sh (+51.04%)
Chuck Royce 925,850 sh (+6.07%)
Barrow, Hanley, Mewhinney & Strauss 269,082 sh (+5.88%)
HOTCHKIS & WILEY 1,391,665 sh (-0.39%)
Arnold Schneider 136,505 sh (-6.83%)
Jim Simons 25,200 sh (-92.18%)
» More
Q4 2016

IVC Guru Trades in Q4 2016

Charles Brandes 1,921,649 sh (+33.78%)
Chuck Royce 1,084,730 sh (+17.16%)
Barrow, Hanley, Mewhinney & Strauss 305,349 sh (+13.48%)
Jim Simons Sold Out
Mariko Gordon 2,972,948 sh (-0.37%)
HOTCHKIS & WILEY 1,385,495 sh (-0.44%)
Arnold Schneider 127,525 sh (-6.58%)
» More
Q1 2017

IVC Guru Trades in Q1 2017

Chuck Royce 1,211,712 sh (+11.71%)
Charles Brandes 2,018,749 sh (+5.05%)
Barrow, Hanley, Mewhinney & Strauss 316,036 sh (+3.50%)
Arnold Schneider 127,525 sh (unchged)
Mariko Gordon 2,922,828 sh (-1.69%)
HOTCHKIS & WILEY 1,338,095 sh (-3.42%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NAS:AXGN, NAS:EXAC, NAS:TCMD, NAS:ELOS, NYSE:CRY, NAS:GNMK, NAS:VRAY, NAS:ARAY, NAS:XENT, OTCPK:CSRMY, NAS:RTIX, NAS:CUTR, OTCPK:XVIPF, AMEX:CVRS, NAS:OFIX, OTCPK:IPDQF, NAS:OBLN, NAS:FONR, NAS:VIVE, OTCPK:DMTRF » details
Traded in other countries:IV3.Germany,
Headquarter Location:USA
Invacare Corp designs, manufactures and distributes health care products including medical equipment for the non-acute care environment, including the home health care, retail and continuing care markets.

Invacare makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and nondelivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.

Ratios

vs
industry
vs
history
PB Ratio 1.20
IVC's PB Ratio is ranked higher than
89% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. IVC: 1.20 )
Ranked among companies with meaningful PB Ratio only.
IVC' s PB Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.03 Max: 1.72
Current: 1.2
0.55
1.72
PS Ratio 0.47
IVC's PS Ratio is ranked higher than
94% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. IVC: 0.47 )
Ranked among companies with meaningful PS Ratio only.
IVC' s PS Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.75
Current: 0.47
0.26
0.75
EV-to-EBIT -29.27
IVC's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. IVC: -29.27 )
Ranked among companies with meaningful EV-to-EBIT only.
IVC' s EV-to-EBIT Range Over the Past 10 Years
Min: -368.8  Med: -4.6 Max: 64.2
Current: -29.27
-368.8
64.2
EV-to-EBITDA -127.38
IVC's EV-to-EBITDA is ranked lower than
99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. IVC: -127.38 )
Ranked among companies with meaningful EV-to-EBITDA only.
IVC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1495  Med: 9.7 Max: 487
Current: -127.38
-1495
487
Shiller PE Ratio 219.61
IVC's Shiller PE Ratio is ranked lower than
92% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. IVC: 219.61 )
Ranked among companies with meaningful Shiller PE Ratio only.
IVC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.28  Med: 49.68 Max: 1513
Current: 219.61
12.28
1513
Current Ratio 1.82
IVC's Current Ratio is ranked lower than
66% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. IVC: 1.82 )
Ranked among companies with meaningful Current Ratio only.
IVC' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 2.2 Max: 3.34
Current: 1.82
1.38
3.34
Quick Ratio 1.13
IVC's Quick Ratio is ranked lower than
69% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. IVC: 1.13 )
Ranked among companies with meaningful Quick Ratio only.
IVC' s Quick Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.52 Max: 2.03
Current: 1.13
0.83
2.03
Days Inventory 70.80
IVC's Days Inventory is ranked higher than
82% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. IVC: 70.80 )
Ranked among companies with meaningful Days Inventory only.
IVC' s Days Inventory Range Over the Past 10 Years
Min: 53.38  Med: 62.35 Max: 70.8
Current: 70.8
53.38
70.8
Days Sales Outstanding 43.80
IVC's Days Sales Outstanding is ranked higher than
88% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. IVC: 43.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
IVC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.53  Med: 51.7 Max: 64.57
Current: 43.8
40.53
64.57
Days Payable 45.57
IVC's Days Payable is ranked lower than
67% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. IVC: 45.57 )
Ranked among companies with meaningful Days Payable only.
IVC' s Days Payable Range Over the Past 10 Years
Min: 34.47  Med: 46.5 Max: 55.1
Current: 45.57
34.47
55.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.34
IVC's Dividend Yield % is ranked lower than
89% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.33 vs. IVC: 0.34 )
Ranked among companies with meaningful Dividend Yield % only.
IVC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.15  Med: 0.28 Max: 0.55
Current: 0.34
0.15
0.55
Forward Dividend Yield % 0.34
IVC's Forward Dividend Yield % is ranked lower than
90% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. IVC: 0.34 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.34
IVC's 5-Year Yield-on-Cost % is ranked lower than
88% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. IVC: 0.34 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IVC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 0.28 Max: 0.55
Current: 0.34
0.15
0.55
3-Year Average Share Buyback Ratio -0.40
IVC's 3-Year Average Share Buyback Ratio is ranked higher than
73% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. IVC: -0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
IVC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.4  Med: -0.7 Max: 0.4
Current: -0.4
-8.4
0.4

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 26.91
IVC's Price-to-Tangible-Book is ranked lower than
82% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. IVC: 26.91 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
IVC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.51  Med: 6.78 Max: 94.62
Current: 26.91
1.51
94.62
Price-to-Intrinsic-Value-Projected-FCF 1.54
IVC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
88% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. IVC: 1.54 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
IVC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.33  Med: 1.09 Max: 7.74
Current: 1.54
0.33
7.74
Price-to-Median-PS-Value 1.12
IVC's Price-to-Median-PS-Value is ranked higher than
66% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. IVC: 1.12 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
IVC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61  Med: 1.7 Max: 3.82
Current: 1.12
0.61
3.82
Earnings Yield (Greenblatt) % -3.41
IVC's Earnings Yield (Greenblatt) % is ranked lower than
67% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. IVC: -3.41 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
IVC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.42  Med: 6.6 Max: 11
Current: -3.41
-3.42
11
Forward Rate of Return (Yacktman) % -20.36
IVC's Forward Rate of Return (Yacktman) % is ranked lower than
94% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. IVC: -20.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
IVC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -21.7  Med: 8.6 Max: 20.4
Current: -20.36
-21.7
20.4

More Statistics

Revenue (TTM) (Mil) $1,022
EPS (TTM) $ -1.57
Beta2.51
Short Percentage of Float18.36%
52-Week Range $8.00 - 16.65
Shares Outstanding (Mil)32.78
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Stakes Charles Brandes Continues to Increase Nov 14 2016 
Mariko Gordon Invested in 5 Companies in 2nd Quarter Aug 21 2016 
Royce Micro-Cap Discovery Fund Shareholder Letter Sep 20 2015 
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
Invacare Declares Quarterly Dividend May 18 2017
Edited Transcript of IVC earnings conference call or presentation 9-May-17 12:30pm GMT May 14 2017
ETFs with exposure to Invacare Corp. : May 11, 2017 May 11 2017
Invacare Corp. :IVC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 May 10 2017
Invacare reports 1Q loss May 08 2017
Invacare Reports Results for the First Quarter 2017 May 08 2017
Invacare Introduces ‘Outcomes by Design’ Program for Post-Acute Care Facilities May 02 2017
Why Invacare Corporation's Shares Rallied 12.1% Today Apr 28 2017
Invacare Reports Completion of Consent Decree Milestones Apr 27 2017
Invacare Corp. – Value Analysis (NYSE:IVC) : April 19, 2017 Apr 19 2017
Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : April 18, 2017 Apr 18 2017
Invacare Corporation to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial... Apr 13 2017
Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : March 31, 2017 Mar 31 2017
Invacare Corporation to Present at 16th Annual Needham Healthcare Conference Mar 24 2017
Invacare Corp. :IVC-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 Feb 15 2017
Edited Transcript of IVC earnings conference call or presentation 9-Feb-17 1:30pm GMT Feb 09 2017
Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December... Feb 09 2017
Invacare Corporation Announces Expiration of Put Option for 4.125% Convertible Senior Subordinated... Jan 31 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat